{"id":731,"date":"2026-10-20T12:12:51","date_gmt":"2026-10-20T01:12:51","guid":{"rendered":"http:\/\/novameds.local\/au\/?post_type=product&#038;p=731"},"modified":"2026-10-20T12:58:41","modified_gmt":"2026-10-20T01:58:41","slug":"catalog-pramipexole-prami-12-mg-0-2-mg-60-capsules","status":"publish","type":"product","link":"https:\/\/novameds.health\/au\/product\/catalog-pramipexole-prami-12-mg-0-2-mg-60-capsules\/","title":{"rendered":"Pramipexole (Prami), 12 mg (0.2 mg\/60 capsules)"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composition and product details\">\n<h2>Composition and product details<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Overview<\/h2>\n<div>\n<p>Pramipexole is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family.<\/p>\n<p>Experimental investigations have examined its interactions with dopamine receptor-mediated signaling pathways, G protein-coupled receptor activation mechanisms, intracellular cAMP regulation, and receptor-ligand dynamics.<\/p>\n<p>Its receptor selectivity profile makes it a valuable research tool for studies of D2\/D3 receptor pharmacology, dopaminergic signaling networks, receptor subtype selectivity, signal transduction mechanisms, and comparative investigations of dopamine receptor-mediated regulatory pathways.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<p><a href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/119570\" target=\"_blank\" rel=\"noopener noreferrer\">Molecular data on PubChem<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>Properties<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C10H17N3S<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>Mirapex (trade name), Sifrol (trade name), PPX, (S)-Pramipexole<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>211.33 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>104632-26-0<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>119570<\/td>\n<\/tr>\n<tr>\n<th>Total Compound Content<\/th>\n<td>12 mg (0.2 mg per capsule)<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Research<\/h2>\n<p>\t\t\t\t\t<span>Pramipexole ((S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine) is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family. Experimental investigations have examined its interactions with dopamine receptor-mediated signaling pathways, G protein-coupled receptor activation mechanisms, intracellular cAMP regulation, and receptor-ligand dynamics. Its high D3 receptor selectivity makes it a valuable research tool for studies of D2\/D3 receptor pharmacology, receptor subtype differentiation, dopaminergic signaling networks, signal transduction mechanisms, and comparative investigations of dopamine receptor-mediated regulatory pathways. Supplied in 0.2 mg capsules. Independently third-party HPLC-tested; COA available per batch.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is pramipexole&#8217;s receptor selectivity profile and why is D3 selectivity research-relevant?<\/span><\/p>\n<\/summary>\n<div>\n<p>Pramipexole exhibits preferential affinity for D3 receptors within the D2-like dopamine receptor family, with additional activity at D2 and D4 receptor subtypes. This receptor selectivity profile makes it a valuable research tool for investigating D3 receptor pharmacology, receptor subtype differentiation, dopaminergic signaling mechanisms, and comparative studies of D2-like receptor function.<\/p>\n<p>Experimental investigations frequently utilize pramipexole to examine receptor-ligand interactions, signal transduction pathways, and subtype-specific dopamine receptor regulation.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>How is pramipexole used in dopaminergic signaling research?<\/span><\/p>\n<\/summary>\n<div>\n<p>Pramipexole is widely used as a selective dopaminergic probe for studies of D2-like receptor activation, G protein-coupled receptor signaling, intracellular cAMP regulation, and dopamine receptor-mediated communication networks. Its well-characterized receptor profile allows researchers to investigate the molecular and signaling consequences of D3-preferring receptor activation and compare these effects with broader dopaminergic signaling mechanisms.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What makes pramipexole useful for dopamine receptor pharmacology studies?<\/span><\/p>\n<\/summary>\n<div>\n<p>Pramipexole&#8217;s high affinity for D3 receptors and established activity at D2-like receptor subtypes make it a valuable reference compound for investigations of receptor selectivity, dopamine receptor signaling pathways, ligand-receptor dynamics, and GPCR-mediated regulatory mechanisms. These characteristics support its use in mechanistic studies of dopaminergic pharmacology and comparative analyses of D2-family receptor function.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<div>\n<p>Capsule excipients are not specified in the available product documentation.<\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Pramipexole is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family.<\/p>\n<p>Presentation: Pramipexole (Prami), 12 mg (0.2 mg\/60 capsules).<\/p>\n<p class=\"nm-research-disclaimer\">For laboratory research only. Not for human or veterinary use.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Illustrative packaging generated with AI.<\/small><\/p>\n","protected":false},"featured_media":923,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[27],"product_tag":[],"nm_classification":[],"class_list":["post-731","product","type-product","status-publish","has-post-thumbnail","product_cat-longevity-cellular-health","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product\/731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/comments?post=731"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/media\/923"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/media?parent=731"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_brand?post=731"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_cat?post=731"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_tag?post=731"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/nm_classification?post=731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}